Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Lipigon Pharmaceuticals AB (publ)
  6. Summary
    LPGO   SE0015382072

LIPIGON PHARMACEUTICALS AB (PUBL)

(LPGO)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
11/23/2021 11/24/2021 11/25/2021 11/26/2021 11/29/2021 Date
7.16(c) 6.92(c) 6.72(c) 6.6(c) 6.4(c) Last
1 956 12 027 15 942 1 614 46 760 Volume
+1.13% -3.35% -2.89% -1.79% -3.03% Change
More quotes
Estimated financial data (e)
Sales 2019 1,74 M 0,19 M 0,19 M
Net income 2019 -4,99 M -0,55 M -0,55 M
Net cash position 2019 2,49 M 0,28 M 0,28 M
P/E ratio 2019 -
Yield 2019 -
Sales 2020 4,01 M 0,44 M 0,44 M
Net income 2020 -8,07 M -0,89 M -0,89 M
Net cash position 2020 12,6 M 1,39 M 1,39 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 62,3 M 6,85 M 6,88 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 6
Free-Float -
More Financials
All news about LIPIGON PHARMACEUTICALS AB (PUBL)
11/24Lipigon Pharmaceuticals AB Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/04Lipigon Pharmaceuticals AB and 5Prime Sciences Enter Partnership to Optimize Coming Cli..
CI
08/26Lipigon Pharmaceuticals AB Publ Reports Earnings Results for the Second Quarter Ended J..
CI
03/23Lipigon Pharmaceuticals AB cancelled the acquisition of antisense drug candidates and p..
CI
03/01Lipigon Pharmaceuticals AB has completed an IPO in the amount of SEK 50.007395 million.
CI
01/19Lipigon Pharmaceuticals AB has filed an IPO in the amount of SEK 50.007395 million.
CI
2020Lipigon Pharmaceuticals AB signed a research, development, and transfer agreement to ac..
CI
2016Lipigon Pharmaceuticals AB announced that it has received funding from Almi Invest AB
CI
More news
News in other languages on LIPIGON PHARMACEUTICALS AB (PUBL)

- No features available -

More news
Chart LIPIGON PHARMACEUTICALS AB (PUBL)
Duration : Period :
Lipigon Pharmaceuticals AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Stefan Kristoffer Nilsson Chief Executive Officer
Michael Owens Chief Financial Officer
Urban Paulsson Chairman
Lars Ole ÷hman Director, Deputy CEO & Head-Business Development
Ingrid Elisabet Olivecrona Director